ResearchHub Endowment
Earn daily Funding Credits to fund science
Paper
Paper
Search
Log in
Sign up
Sign up
Publish
Home
My Funding
Peer Review
Journal
Endowment
Help & resources
Hydroxychloroquine in patients mainly with mild to modera... | ResearchHub
ResearchHub Endowment
Earn daily Funding Credits to fund science
Paper
Paper
Search
Log in
Sign up
Sign up
Publish
Home
My Funding
Peer Review
Journal
Endowment
Help & resources
Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial
5
Paper
Reviews
0
Conversation
0
Bounties
0
Loading PDF viewer…
Topics
#medicine
#covid-19-coronavirus
Other Formats
PDF
